These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases.
    Author: Mesitskaya DF, Syrkin AL, Aksenova MG, Zhang Y, Zamyatnin AA, Kopylov PY.
    Journal: Cardiovasc Hematol Agents Med Chem; 2018; 16(2):81-87. PubMed ID: 30039765.
    Abstract:
    Atherothrombosis-related diseases are one of the world's leading causes of mortality, and thus the search for new therapeutic approaches in this area remains a very urgent task. Modern pharmacogenomic technologies make it possible to obtain valuable data on disease pathogenesis and optimal therapeutic approaches. One promising research direction is the study of the thromboxane A2 - thromboxane A synthase - thromboxane A2 receptor axis. This review summarizes the recent evidence and suggests that systematic works in this area are creating new and promising opportunities in the treatment of patients with cardiovascular diseases.
    [Abstract] [Full Text] [Related] [New Search]